Sichuan Kelun Pharma has announced its intention to acquire stakes in two pharmaceutical companies, one based in Guangxi and another in Changshu.
It will acquire the remaining 20% stake in the Guangxi-based company for $5.3m to obtain 100% ownership, and 35% in the Changshu-based biopharmaceutical company.
French pre-clinical services provider CiToxLAB Group has completed the acquisition of Canadian company, AccelLAB, with the aim of strengthening its position in the non-clinical contract research market and extending its services portfolio to medical devices.
The target company is a pre-clinical contract research organisation that employs approximately 100 people.
CiToxLab operates in France, Canada, Hungary and Denmark with a total of 1,000 staff as a result of the acquisition.